# OcuMension

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ocumension

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: www.ocumension.com
- Total disclosed funding: $200M
- Latest round: Series B (Jun 1, 2019)
- Investors on record: 8

## About

Established in 2018 and based in Shanghai, China, OcuMension is a leading platform in ophthalmology dedicated to providing comprehensive treatment solutions for eye diseases. The company has a robust pipeline of 20 ophthalmic drug assets, covering both anterior and posterior segments of the eye. OcuMension has completed two rounds of financing, raising approximately USD 200 million. The company's business model primarily involves licensing and commercializing overseas drugs within China.

specializes in the development of a diverse range of ophthalmic drugs, with 16 drugs currently in various stages of development. Over 60% of these are acquired through licensing agreements with international pharmaceutical companies, including EyePoint, NicOx SA, Huonland, Senju, and SanBio. The company's product line covers the full spectrum of ophthalmic treatments, aiming to address unmet medical needs in the field of eye care.

The company generates revenue through the licensing, development, and commercialization of ophthalmic drugs, providing innovative treatments for a variety of eye conditions.

## Funding rounds

- Series B, Jun 1, 2019, $180M — General Atlantic, Eight Roads Ventures, Temasek Holdings, Boyu Capital, Cormorant Asset Management, 3W Partners, AVICT Global Holdings
- Series A, Aug 21, 2018, $20M — 6 Dimensions Capital

## Investors

- 6 Dimensions Capital (https://capitalatlas.ai/funds/6-dimensions-capital) — Series A
- General Atlantic (https://capitalatlas.ai/funds/general-atlantic) — Series B
- Eight Roads Ventures (https://capitalatlas.ai/funds/eight-roads-ventures) — Series B
- Temasek Holdings — Series B
- Boyu Capital (https://capitalatlas.ai/funds/boyu-capital) — Series B
- Cormorant Asset Management (https://capitalatlas.ai/funds/cormorant-asset-management) — Series B
- 3W Partners (https://capitalatlas.ai/funds/3w-partners) — Series B
- AVICT Global Holdings — Series B